Acadia Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Acadia Pharmaceuticals has a total of 961 patents globally, out of which 389 have been granted. Of these 961 patents, more than 30% patents are active. The USA is where Acadia Pharmaceuticals has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, the USA seems to be the main focused R&D center of Acadia Pharmaceuticals and is also the origin country of the firm.

Acadia Pharmaceuticals was founded in the year 1993 by Mark R. Brann. Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

Do read about some of the most popular patents of Acadia Pharmaceuticals which have been covered by us in this article and also you can find Acadia Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Acadia Pharmaceuticals patent portfolio.

How many patents does Acadia Pharmaceuticals have?

Acadia Pharmaceuticals has a total of 961 patents globally. These patents belong to 139 unique patent families. Out of 961 patents, 297 patents are active.

How Many Patents did Acadia Pharmaceuticals File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or Grant

Acadia Pharmaceuticals Applications Filed

Acadia Pharmaceuticals Patents Granted

2022

21

16

2021

24

26

2020

43

12

2019

51

4

2018

29

6

2017

31

7

2016

21

10

2015

7

13

2014

21

17

2013

6

24

2012

14

18

2011

8

29

How many Acadia Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

How Many Patents did Acadia Pharmaceuticals File in Different Countries?

Countries in which Acadia Pharmaceuticals Filed Patents

Country

Patents

United States Of America

186

Europe

65

China

52

Australia

47

India

45

Canada

44

Japan

41

Mexico

34

Russia

33

Korea (South)

33

Singapore

30

Hong Kong (S.A.R.)

30

South Africa

28

New Zealand

24

Brazil

24

Austria

20

Germany

20

Israel

19

Denmark

11

Spain

11

Norway

10

Taiwan

8

Slovenia

8

United Kingdom

7

Poland

5

Slovakia

4

Portugal

4

Argentina

3

Cyprus

3

Where are Research Centres of Acadia Pharmaceuticals Patents Located?

10 Best Acadia Pharmaceuticals Patents

US20050085463A1 is the most popular patent in the Acadia Pharmaceuticals portfolio. It has received 208 citations so far from companies like Hoffmann-La Roche.

Below is the list of 10 most cited patents of Acadia Pharmaceuticals:

Publication Number Citation Count
US20050085463A1 208
US6528529B1 178
US20050250767A1 173
US6911452B2 97
WO2006036874A1 88
US6815458B2 85
WO2007047737A1 85
US20090053329A1 82
US6756393B2 81
WO2008048648A2 75

Table of Content

Insights you may find interesting

Related Articles

Pavegen Patents – Insights & Stats (Updated 2024)

Pavegen has a total of 36 patents globally, out of which 26 have been granted. Of these 36 patents, more than 47% patents are active. United Kingdom is where Pavegen has filed the maximum number of patents, followed by Europe (EPO) and Austria. Parallelly, United Kingdom seems to be the

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.